GLG Partners’s Biogen BIIB Stock Holding History

GLG Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$1.04M	Sell	3,268 -732	-18%	-$235K	0.05%	288
2017 Q3	$1.25M	Buy	+4,000	New	+$1.18M	0.07%	225
2017 Q2	–	Sell	-3,043	Closed	-$832K	–	336
2017 Q1	$832K	Buy	+3,043	New	+$860K	0.04%	295
2015 Q4	–	Sell	-30,127	Closed	-$8.79M	–	461
2015 Q3	$8.79M	Buy	30,127 +12,174	+68%	+$4.02M	0.23%	122
2015 Q2	$7.25M	Buy	17,953 +13,903	+343%	+$5.58M	0.19%	135
2015 Q1	$1.71M	Sell	4,050 -5,785	-59%	-$2.28M	0.06%	253
2014 Q4	$3.34M	Buy	9,835 +5,396	+122%	+$1.75M	0.1%	197
2014 Q3	$1.47M	Sell	4,439 -7,026	-61%	-$2.32M	0.03%	322
2014 Q2	$3.62M	Sell	11,465 -76,589	-87%	-$23.1M	0.09%	212
2014 Q1	$26.9M	Buy	+88,054	New	+$28M	0.53%	55
2013 Q3	–	Sell	-1,105	Closed	-$238K	–	180
2013 Q2	$238K	Buy	+1,105	New	+$236K	0.01%	266

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

GLG Partners's BIIB Position: Q4 2017 in Review

GLG Partners reduced its Biogen (BIIB) stake by 18% in Q4 2017, selling an estimated $235K and leaving 3,268 shares worth $1.04M. The position accounts for 0.05% of the portfolio, ranked #288.

GLG Partners first reported a position in BIIB in Q2 2013 and has held it in 11 quarters since. The position peaked at $26.9M in Q1 2014. 1,123 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

GLG Partners held 3,268 shares of Biogen worth $1.04M as of Q4 2017.
GLG Partners sold 732 Biogen shares in Q4 2017, an estimated $235K.
Biogen made up 0.05% of GLG Partners's portfolio in Q4 2017, its #288 holding.
GLG Partners first reported a position in Biogen in Q2 2013 and has held it in 11 quarters since.
GLG Partners's Biogen position peaked at $26.9M in Q1 2014.
1,123 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.